Protagonist Therapeutics
PTGX
PTGX
85 hedge funds and large institutions have $605M invested in Protagonist Therapeutics in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 42 increasing their positions, 14 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
10% more funds holding
Funds holding: 77 → 85 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
85
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$38.9M | |
| 2 | +$29.6M | |
| 3 | +$18.9M | |
| 4 |
DM
Deerfield Management
New York
|
+$17.9M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$17.7M |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$3.31M | |
| 3 | -$1.61M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.12M |
| 5 |
VA
VR Adviser
New York
|
-$799K |